Related references
Note: Only part of the references are listed.Disease trends after Helicobacter pylori eradication based on Japanese nationwide claims and the health check-up database
Kazuhiro Mizukami et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2023)
Lactoferrin: A glycoprotein that plays an active role in human health
Xiang Cao et al.
FRONTIERS IN NUTRITION (2023)
Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis
Alexander C. Ford et al.
GUT (2022)
Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit-risk approach?
Stanislav Sitkin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2022)
Protective effects of recombinant lactoferrin with different iron saturations on enteritis injury in young mice
L. L. Fan et al.
JOURNAL OF DAIRY SCIENCE (2022)
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Peter Malfertheiner et al.
GUT (2022)
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis
Mei-Jyh Chen et al.
HELICOBACTER (2022)
Vonoprazan-containingHelicobacter pyloritriple therapies contribution to global antimicrobial resistance
David Y. Graham et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides
Spela Gruden et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment
Jacek Baj et al.
CELLS (2021)
Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)
Olga P. Nyssen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing
Si-Yu Li et al.
HELICOBACTER (2021)
An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment
Yi Ying Cheok et al.
MICROORGANISMS (2021)
The Innate Immune Glycoprotein Lactoferrin Represses the Helicobacter pylori cag Type IV Secretion System
Jacky Lu et al.
CHEMBIOCHEM (2021)
The prevention of gastric cancer by Helicobacter pylori eradication
Erick A. Argueta et al.
CURRENT OPINION IN GASTROENTEROLOGY (2021)
Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial
Fahmy H. Hablass et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2021)
Lactoferrin: Major Physiological Functions and Applications
Liyuan Hao et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2019)
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis
Kentaro Sugano
GASTRIC CANCER (2019)
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition
Mototsugu Kato et al.
HELICOBACTER (2019)
Multifunctional capacity and therapeutic potential of lactoferrin
Luis Moreno-Exposito et al.
LIFE SCIENCES (2018)
Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis
Skander Hathroubi et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2018)
Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma
Chanbora Chea et al.
PLOS ONE (2018)
The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial
Luyi Chen et al.
EBIOMEDICINE (2018)
Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks A meta-analysis
Qiuping Li et al.
MEDICINE (2017)
Population screening and treatment of Helicobacter pylori infection
Anthony O'Connor et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Bovine lactoferrin reduces extra-territorial facial allodynia/hyperalgesia following a trigeminal nerve injury in the rat
Kayo Horie et al.
BRAIN RESEARCH (2017)
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
Carlo A. Fallone et al.
GASTROENTEROLOGY (2016)
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study
Kazunari Murakami et al.
GUT (2016)
Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori
Yuping Yuan et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Immunomodulatory effects of lactoferrin
Tania Siqueiros-Cendon et al.
ACTA PHARMACOLOGICA SINICA (2014)
Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report
Peter Malfertheiner et al.
GUT (2012)
Unique Host Iron Utilization Mechanisms of Helicobacter pylori Revealed with Iron-Deficient Chemically Defined Media
Olga Senkovich et al.
INFECTION AND IMMUNITY (2010)
Prevention of Gastric Cancer by Helicobacter pylori Eradication
Masahiro Asaka et al.
INTERNAL MEDICINE (2010)
Siderophore-mediated iron acquisition in the staphylococci
Federico C. Beasley et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication
A. Sachdeva et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The Structural Basis for the Prevention of Nonsteroidal Antiinflammatory Drug-Induced Gastrointestinal Tract Damage by the C-Lobe of Bovine Colostrum Lactoferrin
Rafia Mir et al.
BIOPHYSICAL JOURNAL (2009)
Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin
J. L. Hayworth et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Meta-Analysis: The Effect of Supplementation with Lactoferrin on Eradication Rates and Adverse Events During Helicobacter pylori Eradication Therapy
Jian Zou et al.
HELICOBACTER (2009)
Annual Change of Primary Resistance to Clarithromycin among Helicobacter pylori Isolates from 1996 through 2008 in Japan
Noriyuki Horiki et al.
HELICOBACTER (2009)
Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H-pylori growth and gastric inflammation in mice
H. Q. Huynh et al.
LETTERS IN APPLIED MICROBIOLOGY (2009)
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy:: A multicentre study
A. Zullo et al.
DIGESTIVE AND LIVER DISEASE (2007)
Helicobacter pylori eradication:: A randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics
Nicola de Bortoli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Pathogenesis of Helicobacter pylori infection
Johannes G. Kusters et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Bovine lactoferrin for Helicobacter pylori eradication:: an open, randomized, multicentre study
F Di Mario et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Quadruple therapy with lactoferrin for Helicobacter pylori eradication:: A randomised, multicentre study
A Zullo et al.
DIGESTIVE AND LIVER DISEASE (2005)
Helicobacter pylori cag-type IV secretion systems facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils
G Rieder et al.
GASTROENTEROLOGY (2005)
The spatial orientation of Helicobacter pylori in the gastric mucus
S Schreiber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lactoferrin - a multifunctional protein with antimicrobial properties
S Farnaud et al.
MOLECULAR IMMUNOLOGY (2003)
Use of bovine lactoferrin for Helicobacter pylori eradication
F Di Mario et al.
DIGESTIVE AND LIVER DISEASE (2003)
Use of lactoferrin for Helicobacter pylori eradication -: Preliminary results
F Di Mario et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
A component of innate immunity prevents bacterial biofilm development
PK Singh et al.
NATURE (2002)
Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans
I Sakamoto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice
EJ Dial et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)